Atlas Trials

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

Clinical trial NCT07038837 · RECRUITING

Trial details

NCT number
NCT07038837
Sponsor
Epicentre
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Malaria InfectionMalaria Vaccines
Start date
2025-06-16
Primary completion
2026-12-01
Enrollment
70000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.